Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 847

MOTION in Limine No. 12: Exclude Reference to Amgen's "Monopoly" and the Patents-in-Suit as Limiting Consumer Choice by Amgen Inc..(Gottfried, Michael)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 847

Case 1:05-cv-12237-WGY

Document 847

Filed 08/20/2007

Page 1 of 3

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN, INC., ) ) Plaintiff, ) v. ) ) F. HOFFMANN-LAROCHE LTD., ) a Swiss Company, ROCHE DIAGNOSTICS ) GMBH, a German Company, and ) HOFFMANN LAROCHE INC., a New ) Jersey Corporation, ) ) Defendants. )

Civil Action No. 05 CV 12237 WGY

PLAINTIFF AMGEN'S MOTION IN LIMINE NO. 12: EXCLUDE REFERENCE TO AMGEN'S "MONOPOLY" AND THE PATENTS-IN-SUIT AS LIMITING CONSUMER CHOICE Pursuant to FRE 402 and 403, Plaintiff Amgen Inc. ("Amgen") requests that this Court preclude Defendants F. Hoffmann-La Roche Ltd., Roche Diagnostics GmbH, and Hoffmann-La Roche Inc. (collectively "Roche") from arguing or introducing evidence during infringement, validity or enforceability proceedings that Amgen's patents-in-suit constitute "monopolies," or that assertion of Amgen's patent rights will constitute monopolistic or anticompetitive behavior or limit consumer choice. Although patents are sometimes loosely described as granting a "legal monopoly" to the inventor, the law is well-established that patents are not to be regarded as monopolies, and that it is improper to characterize the exercise of patent rights as monopolistic or anticompetitive behavior. Amgen requests that this Court preclude the following arguments and evidence during the infringement, validity and enforceability proceedings under FRE 402 and 403: a. Any reference to Amgen's patents-in-suit as "monopolies" or that Amgen's patent enforcement constitutes anticompetitive or monopolistic behavior; b. That Amgen's patent enforcement will limit or negatively affect consumer choice.

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 847

Filed 08/20/2007

Page 2 of 3

In support of this motion, Amgen submits a brief.

Date: August 20, 2007

Respectfully Submitted, AMGEN INC., By its attorneys, /s/ Michael R. Gottfried D. DENNIS ALLEGRETTI (BBO#545511) MICHAEL R. GOTTFRIED (BBO#542156) PATRICIA R. RICH (BBO#640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: [phone] Facsimile: [phone] LLOYD R. DAY, JR. (pro hac vice) DAY CASEBEER MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: [phone] Facsimile: [phone] WILLIAM GAEDE III (pro hac vice) McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: [phone] Facsimile: [phone] KEVIN M. FLOWERS (pro hac vice) MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago IL 60606 Telephone: [phone] Facsimile: [phone]

Of Counsel: STUART L. WATT WENDY A. WHITEFORD MONIQUE L. CORDRAY DARRELL G. DOTSON KIMBERLIN L. MORLEY ERICA S. OLSON AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1789 [phone]

2

Case 1:05-cv-12237-WGY

Document 847

Filed 08/20/2007

Page 3 of 3

CERTIFICATE PURSUANT TO LOCAL RULE 7.1 I certify that counsel for the parties have conferred in an attempt to resolve or narrow the issues presented by this motion and no agreement was reached. /s/ Michael R. Gottfried Michael R. Gottfried

CERTIFICATE OF SERVICE I hereby certify that this document filed through the Electronic Case Filing (ECF) system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF) and paper copies will be sent to those indicated as nonregistered participants, on the above date. /s/ Michael R. Gottfried Michael R. Gottfried